Abstract: Surfactin A, a cyclic lipopeptide from Bacillus subtilis, exhibited a wide spectrum therapeutic profile. But it's drug likeness has not been thoroughly assessed yet. Thus, the objective of the present work was to simulate it's drug likeness by predicting the pharmacokinetic and toxicological profiling parameters. ADME profiling was carried out by using StarDrop. Integrated Derek Nexus with StarDrop was used for the toxicological prediction against 40 toxicological end points. Metabolism of Surfactin A was modelled with three isoforms of cytochrome P450: 3A4, 2D6 and 2C9; and composite site lability (CSL) was analyzed. Only the alkyl regions in Surfactin A were found to be moderately labile to metabolism, indicating their tendency to get oxidized and form dealkylated Surfactin A. Toxicological prediction suggested that Surfactin A is not carcinogenic, mutagenic, teratogenic, hepatotoxic, neurotoxic, nephrotoxic and even clean for rest of the toxicological end points. Good human intestinal absorption (HIA) and poor blood brain barrier (BBB) crossing ability were also predicted for Surfactin A.
Introduction
Biosurfactants have potential industrial applications, for example, in digestion of persistent organic pollutants (POPs), as stabilizing agents in food processing and foam formation to name a few [1] . Bacillus subtilis yields a well known biosurfactant as secondary metabolite, Surfactin which exists in four isomeric forms viz. Surfactin A -D. Physiologically, it acts as anti-fibrin clotting agent, as an agent for cell lysis, anti-diabetic SciForum http://sciforum.net/conference/mol2net-1 adjuvant, anti-inflammatory agent etc [2] [3] [4] . But so far, its drug metabolism, pharmacokinetics and toxicological parameters have not be reported. In this study, we predict these features with the aid of computational tools.
Results and Discussion
Composite site lability of 0.9219 predicted the high rate of metabolism with 3A4 isoform of cytochrome P450 ( Table 1 ). The CYP3A4 is the main isoform of P450 superfamily which resides majorly in the liver and is responsible for the metabolism of many drugs. Hence, the lability of surfactin with this isoform predicts the significant affinity. Interaction of surfactin A with CYP3A4 may increase/decrease its physiological effects which need to be assessed further. Amphiphillic nature of the surfactin A can be computed from its LogS and LogP values. Aliphatic elements like hydrocarbon side chain influence the hydrophobicity positively while the peptidal bonds have some negative influence on the hydrophobicity (Figure 1) . Carboxyl group of aspartic acid and glutamic acid improved the solubility of surfactin A. Further, the tendency to get absorbed through human intestinal barrier and the inability to cross blood brain barrier makes it a potential candidate for oral and non-CNS drug.
Derek Nexus software predicted that the surfactin A doesn't have any potential site which can cause toxicity against any of the 40 tested toxicological end points. [blood]), BBB category, HIA category, P-gp category, 2D6 affinity category, PPB90 category, developmental toxicological category and composite site lability of these molecules on 3A4 isoform of cytochrome P450 [5] [6] .
Toxicological Studies
Derek Nexus module of LHASA Ltd. was used to calculate toxicological endpoints like carcinogenicity, photo-carcinogenicity, chromosome damage in vitro, chromosome damage in vivo, photo-induced chromosome damage in vitro, genotoxicity in vitro, genotoxicity in vivo, photogenotoxicity in vitro, photogenotoxicity in vivo, hepatotoxicity, irritation (of the eye), irritation (of the gastrointestinal tract), irritation (of the respiratory tract), irritation (of the skin), lachrymation, HERG channel inhibition in vitro, alpha-2-mu-globulin nephropathy, anaphylaxis, bladder urothelial hyperplasia, cardiotoxicity, cerebral oedema, chloracne, cholinesterase inhibition, cumulative effect on white cell count and immunology, cyanide-type effects, high acute toxicity, methaemoglobinaemia, nephrotoxicity, neurotoxicity, oestrogenicity, peroxisome proliferation, phospholipidosis, phototoxicity, pulmonary toxicity, uncoupler of oxidative phosphorylation, developmental toxicity, teratogenicity, testicular toxicity, ocular toxicity, mutagenicity in vitro, mutagenicity in vivo, photomutagenicity in vitro, thyroid toxicity, photoallergenicity, skin sensitization, occupational asthma and respiratory sensitization [5] [6] .
Conclusions
In this study, prediction of the drug metabolism, pharmacokinetic, and toxicological parameters were investigated for the well known biosurfactant, Surfactin A produced by Bacillus subtilis. Computataional tools predicted Surfactin A as a molecule, which can be studied and explored further for lead optimization.
